Kim, S.-M.; Park, K.; Lim, J.H.; Yun, H.J.; Kim, S.Y.; Choi, K.H.; Kim, C.W.; Lee, J.H.; Weicker, R.; Pan, C.-H.;
et al. Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid Carcinoma. Int. J. Mol. Sci. 2022, 23, 10378.
https://doi.org/10.3390/ijms231810378
AMA Style
Kim S-M, Park K, Lim JH, Yun HJ, Kim SY, Choi KH, Kim CW, Lee JH, Weicker R, Pan C-H,
et al. Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid Carcinoma. International Journal of Molecular Sciences. 2022; 23(18):10378.
https://doi.org/10.3390/ijms231810378
Chicago/Turabian Style
Kim, Seok-Mo, Keunwan Park, Jin Hong Lim, Hyeok Jun Yun, Sang Yong Kim, Kyung Hwa Choi, Chan Wung Kim, Jae Ha Lee, Raymond Weicker, Cheol-Ho Pan,
and et al. 2022. "Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid Carcinoma" International Journal of Molecular Sciences 23, no. 18: 10378.
https://doi.org/10.3390/ijms231810378
APA Style
Kim, S. -M., Park, K., Lim, J. H., Yun, H. J., Kim, S. Y., Choi, K. H., Kim, C. W., Lee, J. H., Weicker, R., Pan, C. -H., & Park, K. C.
(2022). Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid Carcinoma. International Journal of Molecular Sciences, 23(18), 10378.
https://doi.org/10.3390/ijms231810378